Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

670 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biochemical Failure Is Not a Surrogate End Point for Overall Survival in Recurrent Prostate Cancer: Analysis of NRG Oncology/RTOG 9601.
Jackson WC, Tang M, Schipper MJ, Sandler HM, Zumsteg ZS, Efstathiou JA, Shipley WU, Seiferheld W, Lukka HR, Bahary JP, Zietman AL, Pisansky TM, Zeitzer KL, Hall WA, Dess RT, Lovett RD, Balogh AG, Feng FY, Spratt DE. Jackson WC, et al. Among authors: spratt de. J Clin Oncol. 2022 Jun 23:JCO2102741. doi: 10.1200/JCO.21.02741. Online ahead of print. J Clin Oncol. 2022. PMID: 35737923
Harm-to-Benefit of Three Decades of Prostate Cancer Screening in Black Men.
Basourakos SP, Gulati R, Vince RA Jr, Spratt DE, Lewicki PJ, Hill A, Nyame YA, Cullen J, Markt SC, Barbieri CE, Hu JC, Trapl E, Shoag JE. Basourakos SP, et al. Among authors: spratt de. NEJM Evid. 2022 Jun;1(6):10.1056/evidoa2200031. doi: 10.1056/evidoa2200031. Epub 2022 May 15. NEJM Evid. 2022. PMID: 35721307 Free PMC article.
Lutetium-177 DOTATATE: A Practical Review.
Jia AY, Kashani R, Zaorsky NG, Spratt DE, Kiess AP, Michalski JM, Zoberi JE, Kim H, Baumann BC. Jia AY, et al. Among authors: spratt de. Pract Radiat Oncol. 2022 Jul-Aug;12(4):305-311. doi: 10.1016/j.prro.2022.02.002. Pract Radiat Oncol. 2022. PMID: 35717045 Review.
Prostate cancer therapy personalization via multi-modal deep learning on randomized phase III clinical trials.
Esteva A, Feng J, van der Wal D, Huang SC, Simko JP, DeVries S, Chen E, Schaeffer EM, Morgan TM, Sun Y, Ghorbani A, Naik N, Nathawani D, Socher R, Michalski JM, Roach M 3rd, Pisansky TM, Monson JM, Naz F, Wallace J, Ferguson MJ, Bahary JP, Zou J, Lungren M, Yeung S, Ross AE; NRG Prostate Cancer AI Consortium, Sandler HM, Tran PT, Spratt DE, Pugh S, Feng FY, Mohamad O. Esteva A, et al. Among authors: spratt de. NPJ Digit Med. 2022 Jun 8;5(1):71. doi: 10.1038/s41746-022-00613-w. NPJ Digit Med. 2022. PMID: 35676445 Free PMC article.
Genomic biomarkers to guide precision radiotherapy in prostate cancer.
Sutera P, Deek MP, Van der Eecken K, Wyatt AW, Kishan AU, Molitoris JK, Ferris MJ, Siddiqui MM, Rana Z, Mishra MV, Kwok Y, Davicioni E, Spratt DE, Ost P, Feng FY, Tran PT. Sutera P, et al. Among authors: spratt de. Prostate. 2022 Aug;82 Suppl 1(Suppl 1):S73-S85. doi: 10.1002/pros.24373. Prostate. 2022. PMID: 35657158 Free PMC article. Review.
Validation of the Decipher Genomic Classifier in Patients receiving Salvage Radiotherapy without Hormone Therapy after Radical Prostatectomy - An Ancillary Study of the SAKK 09/10 Randomized Clinical Trial.
Pra AD, Ghadjar P, Hayoz S, Liu VYT, Spratt DE, Thompson DJS, Davicioni E, Huang HC, Zhao X, Liu Y, Schär C, Gut P, Plasswilm L, Hölscher T, Polat B, Hildebrandt G, Müller AC, Pollack A, Thalmann GN, Zwahlen D, Aebersold DM. Pra AD, et al. Among authors: spratt de. Ann Oncol. 2022 May 27:S0923-7534(22)01205-4. doi: 10.1016/j.annonc.2022.05.007. Online ahead of print. Ann Oncol. 2022. PMID: 35636621 Free article.
670 results